Hart S. Dengler

1.0k total citations
7 papers, 666 citations indexed

About

Hart S. Dengler is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hart S. Dengler has authored 7 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hart S. Dengler's work include T-cell and B-cell Immunology (3 papers), IL-33, ST2, and ILC Pathways (2 papers) and Asthma and respiratory diseases (2 papers). Hart S. Dengler is often cited by papers focused on T-cell and B-cell Immunology (3 papers), IL-33, ST2, and ILC Pathways (2 papers) and Asthma and respiratory diseases (2 papers). Hart S. Dengler collaborates with scholars based in United States, Australia and Bulgaria. Hart S. Dengler's co-authors include Robert C. Rickert, Karen C. Arden, Ronald A. DePinho, Sidne A. Omori, Gisele V. Baracho, Shane Bruckner, Diego H. Castrillón, Nico Ghilardi, Jennifer H. Cox and Noelyn M. Kljavin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Hart S. Dengler

7 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hart S. Dengler United States 7 448 249 101 56 55 7 666
Tomomitsu Doi Japan 15 326 0.7× 271 1.1× 127 1.3× 18 0.3× 41 0.7× 29 661
Pilar M. Domínguez United States 10 282 0.6× 224 0.9× 89 0.9× 29 0.5× 28 0.5× 11 518
Jan Kubach Germany 9 798 1.8× 222 0.9× 156 1.5× 60 1.1× 18 0.3× 9 1.0k
Rinako Nakagawa United Kingdom 15 390 0.9× 319 1.3× 94 0.9× 16 0.3× 49 0.9× 24 719
Kei Haniuda Japan 11 449 1.0× 147 0.6× 70 0.7× 55 1.0× 20 0.4× 22 607
Thamara Beyer Germany 8 615 1.4× 102 0.4× 205 2.0× 33 0.6× 39 0.7× 16 768
Ryuta Mukasa Japan 7 912 2.0× 221 0.9× 184 1.8× 73 1.3× 18 0.3× 11 1.1k
Jung Won Kang South Korea 6 310 0.7× 78 0.3× 87 0.9× 25 0.4× 65 1.2× 10 482
Shinji Sogo Japan 11 396 0.9× 182 0.7× 100 1.0× 38 0.7× 61 1.1× 21 638
Emily Rowell United States 9 675 1.5× 295 1.2× 169 1.7× 51 0.9× 12 0.2× 11 913

Countries citing papers authored by Hart S. Dengler

Since Specialization
Citations

This map shows the geographic impact of Hart S. Dengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hart S. Dengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hart S. Dengler more than expected).

Fields of papers citing papers by Hart S. Dengler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hart S. Dengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hart S. Dengler. The network helps show where Hart S. Dengler may publish in the future.

Co-authorship network of co-authors of Hart S. Dengler

This figure shows the co-authorship network connecting the top 25 collaborators of Hart S. Dengler. A scholar is included among the top collaborators of Hart S. Dengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hart S. Dengler. Hart S. Dengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Maher, Jonathan, Rui Zhang, Gopinath S. Palanisamy, et al.. (2022). Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFβ pathway inhibition. Toxicology and Applied Pharmacology. 438. 115905–115905. 7 indexed citations
2.
Braithwaite, Irene, Fang Cai, Jennifer Tom, et al.. (2021). Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial. Journal of Allergy and Clinical Immunology. 148(3). 783–789. 33 indexed citations
3.
Zak, Mark, et al.. (2019). Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma. Bioorganic & Medicinal Chemistry Letters. 29(20). 126658–126658. 22 indexed citations
4.
Shih, Vincent Feng-Sheng, Jennifer H. Cox, Noelyn M. Kljavin, et al.. (2014). Homeostatic IL-23 receptor signaling limits Th17 response through IL-22–mediated containment of commensal microbiota. Proceedings of the National Academy of Sciences. 111(38). 13942–13947. 88 indexed citations
5.
Batten, Marcel, Nandhini Ramamoorthi, Noelyn M. Kljavin, et al.. (2010). IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. The Journal of Experimental Medicine. 207(13). 2895–2906. 163 indexed citations
6.
Browne, Cecille D., et al.. (2009). Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell Anergy. Immunity. 31(5). 749–760. 87 indexed citations
7.
Dengler, Hart S., Gisele V. Baracho, Sidne A. Omori, et al.. (2008). Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nature Immunology. 9(12). 1388–1398. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026